Date published: 2026-4-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

VGAT Inhibitors

VGAT inhibitors encompass a range of chemicals that, although not directly targeting VGAT, influence its activity through various biochemical and cellular pathways. The primary mechanism by which these inhibitors exert their effects is by modulating the intracellular environment or signaling pathways that are indirectly related to VGAT's function. These inhibitors often target systems crucial for the maintenance of neuronal homeostasis and neurotransmitter dynamics. For example, inhibitors of the vacuolar-type H+-ATPase, such as Bafilomycin A1 and Concanamycin A, disrupt vesicular acidification. This process is essential for the proper functioning of VGAT, as it relies on the proton gradient to drive the transport of neurotransmitters into synaptic vesicles. By destabilizing this gradient, these inhibitors indirectly impede VGAT's ability to load neurotransmitters into vesicles, thus reducing the efficacy of synaptic transmission.

Other chemicals in this class function by altering ion channel activity or neurotransmitter receptor signaling. Compounds like Verapamil and Tetrodotoxin, which modulate calcium and sodium ion dynamics respectively, impact VGAT activity indirectly by influencing the overall excitability of neurons and the release of neurotransmitters. The precise regulation of ion channels is pivotal for action potential propagation and synaptic release mechanisms, processes that are inherently connected to VGAT's role in neurotransmitter transport. Additionally, antagonists of specific neurotransmitter receptors, such as Gabazine (GABA-A receptor antagonist) and CGP 55845 (GABA-B receptor antagonist), alter the synaptic levels of neurotransmitters. By modulating receptor activity, these compounds influence the feedback mechanisms that regulate VGAT-mediated GABA transport. In a similar vein, compounds that affect glutamatergic signaling, such as Kynurenic Acid and Fluorowillardiine, indirectly impact VGAT by shifting the balance of excitatory and inhibitory neurotransmission in the brain.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Bafilomycin A1 is a specific inhibitor of the vacuolar-type H+-ATPase. By inhibiting this ATPase, it disrupts vesicular acidification, which is crucial for VGAT function. This indirect inhibition affects the loading of neurotransmitters into vesicles, thus impacting VGAT-mediated transport.

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$66.00
$167.00
$673.00
$2601.00
109
(2)

Similar to Bafilomycin A1, Concanamycin A specifically inhibits the vacuolar-type H+-ATPase. This inhibition leads to reduced vesicular acidification, subsequently affecting VGAT's ability to transport neurotransmitters into vesicles.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Verapamil, a calcium channel blocker, indirectly influences VGAT by altering calcium dynamics within the neuron. Calcium ions play a significant role in neurotransmitter release, and by modulating these levels, Verapamil can indirectly impact VGAT activity.

Kynurenic acid

492-27-3sc-202683
sc-202683A
sc-202683B
250 mg
1 g
5 g
$26.00
$57.00
$138.00
6
(1)

Kynurenic Acid is a broad-spectrum antagonist of ionotropic glutamate receptors. By modulating glutamatergic signaling, it indirectly influences VGAT, as glutamatergic pathways are involved in regulating GABAergic neuron activity.

Riluzole

1744-22-5sc-201081
sc-201081A
sc-201081B
sc-201081C
20 mg
100 mg
1 g
25 g
$20.00
$193.00
$213.00
$317.00
1
(1)

Riluzole modulates glutamatergic neurotransmission and has been shown to enhance GABAergic signaling. By altering the balance of excitatory and inhibitory neurotransmission, it indirectly influences VGAT activity.

Gabazine

105538-73-6sc-211552
10 mg
$714.00
3
(0)

Gabazine is a GABA-A receptor antagonist. It impacts VGAT function indirectly by modulating GABAergic signaling, influencing synaptic GABA levels and, consequently, VGAT-mediated GABA transport.

(S)-(−)-5-Fluorowillardiine

140187-23-1sc-361326
sc-361326A
10 mg
50 mg
$192.00
$774.00
1
(0)

This compound is an AMPA receptor agonist. By potentiating excitatory neurotransmission, it indirectly influences VGAT, as changes in excitatory signaling can affect the balance of neurotransmitter release and uptake, including VGAT-mediated processes.